Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Linehan

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancerW D Figg, W Dahut, P Duray, et al.
Cancer Research|December 20, 1999
Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridizationS D Pack, B Zbar, E Pak, et al.
The Journal of Pathology|February 6, 2007
Identification of a unique epigenetic sub-microenvironment in prostate cancerJ Rodriguez-Canales, J C Hanson, M A Tangrea, et al.
Biochimica Et Biophysica Acta|March 18, 1996
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinomaJ R Gnarra, D R Duan, Y Weng, et al.
Cancer Research|December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinomaC P Paweletz, D K Ornstein, M J Roth, et al.
Advances in Virology|February 8, 2012
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood SamplesM F Kearney, K Lee, R K Bagni, et al.
Oncogenesis|April 5, 2013
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationL E Moore, E Jaeger, M L Nickerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2016
International cancer seminars: a focus on kidney cancerG Scelo, J N Hofmann, R E Banks, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancerW D Figg, W Dahut, P Duray, et al.
Cancer Research|December 20, 1999
Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridizationS D Pack, B Zbar, E Pak, et al.
The Journal of Pathology|February 6, 2007
Identification of a unique epigenetic sub-microenvironment in prostate cancerJ Rodriguez-Canales, J C Hanson, M A Tangrea, et al.
Biochimica Et Biophysica Acta|March 18, 1996
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinomaJ R Gnarra, D R Duan, Y Weng, et al.
Cancer Research|December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinomaC P Paweletz, D K Ornstein, M J Roth, et al.
Advances in Virology|February 8, 2012
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood SamplesM F Kearney, K Lee, R K Bagni, et al.
Oncogenesis|April 5, 2013
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationL E Moore, E Jaeger, M L Nickerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2016
International cancer seminars: a focus on kidney cancerG Scelo, J N Hofmann, R E Banks, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
Pageof 26